Study Stopped
Sponsor decision (due to low subject enrollment)
A Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT
An Open-label, Non-randomized, Multi-center Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT
1 other identifier
interventional
77
1 country
1
Brief Summary
To compare computed tomography (CT) images (pictures) of the coronary arteries using the General Electric (GE) LightSpeed VCT scanner with x-ray coronary angiography in patients referred for an x-ray coronary angiography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable coronary-artery-disease
Started Oct 2005
Shorter than P25 for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 6, 2006
CompletedFirst Posted
Study publicly available on registry
July 10, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2006
CompletedApril 30, 2019
April 1, 2019
1 year
July 6, 2006
April 26, 2019
Conditions
Study Arms (1)
64 Channel VCT
EXPERIMENTALAll subjects underwent Coronary Computed Tomographic Angiography (CCTA) after receiving an intravenous (IV) administration of Visipaque (320 mgI/mL), to be followed by catheter coronary angiography (CATH).
Interventions
Eligibility Criteria
You may qualify if:
- Patients scheduled for elective diagnostic catheterization OR
- Elective diagnostic catheterization has been performed within the past 2 weeks but no less than 24 hours prior to the coronary CTA procedure with no intervention performed or change of the patient clinical status.
- Age ≥18 years but ≤75 years.
You may not qualify if:
- Prior coronary stent implantation
- Prior coronary artery bypass grafting or other heart surgery
- Prior pacemaker or internal defibrillator lead implantation
- Prior artificial heart valve
- Biochemical renal insufficiency (CrSerum \> 1.6) or on dialysis
- Resting HR \> 100 at the time of enrollment
- Contraindication to β-blockade or calcium channel blocker
- NYHA-IV
- High-grade atrioventricular (AV) block
- Systolic blood pressure \<90 mm Hg
- Severe asthma or active bronchospasm and/or chronic obstructive pulmonary disease
- Atrial fibrillation
- Inability to provide informed consent
- Evidence of ongoing or active clinical instability
- Acute chest pain (sudden onset)
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GE Healthcarelead
Study Sites (1)
GE Healthcare
Princeton, New Jersey, 08540, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Robert Centofanti, MS
GE Healthcare
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2006
First Posted
July 10, 2006
Study Start
October 1, 2005
Primary Completion
October 1, 2006
Study Completion
October 1, 2006
Last Updated
April 30, 2019
Record last verified: 2019-04